IP Verse

Treatment Of Cancer Using Chimeric Antigen Receptor - EP3119423

PATENT ANALYSIS

Patent Details

Grant Date
Dec 14, 2022
Company
NOVARTIS AG
Oppositions

MARGARET DIXON LIMITED

MURGITROYD & COMPANY LIMITED

PATENT BOUTIQUE LLP

More patents of Novartis Ag

EP3124018

EP3023095

EP3626270

Want to monitor this patent?

Feel free to send us a message here and we will get back to you